HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emilio Paolo Alessandrino Selected Research

Emilio Paolo Alessandrino Research Topics

Disease

9Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2017 - 12/2002
6Infections
01/2022 - 04/2005
4Cytomegalovirus Infections (Inclusion Disease)
01/2022 - 04/2005
3Leukemia
08/2013 - 12/2002
2Graft vs Host Disease (Graft-Versus-Host Disease)
08/2013 - 02/2008
2Iron Overload
10/2011 - 03/2010
2Multiple Myeloma
06/2007 - 09/2004
1Primary Myelofibrosis (Myelosclerosis)
01/2019
1Splenomegaly
01/2019
1Bacteremia
11/2017
1Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
01/2017
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
03/2015
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2014
1Radiculopathy (Radiculopathy, Cervical)
10/2012
1Respiratory Tract Diseases (Respiratory Tract Disease)
09/2012
1Coinfection
09/2012
1Viremia
04/2005

Drug/Important Bio-Agent (IBA)

2Antiviral Agents (Antivirals)IBA
01/2021 - 10/2012
2fludarabineIBA
01/2019 - 11/2015
2Busulfan (Busulfex)FDA Link
01/2019 - 11/2015
1letermovirIBA
01/2022
1CytokinesIBA
01/2021
1Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
01/2019
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2015
1AnthracyclinesIBA
03/2015
1H antigenIBA
08/2013
1RNA (Ribonucleic Acid)IBA
09/2012
1IronIBA
10/2011
1Ferritins (Ferritin)IBA
03/2010
1SteroidsIBA
02/2008
1Interleukin-2 (IL2)IBA
02/2008
1Interferon-gamma (Interferon, gamma)IBA
02/2008
1Ganciclovir (Cytovene)FDA LinkGeneric
04/2005
1Biomarkers (Surrogate Marker)IBA
04/2005
1Alkylating AgentsIBA
09/2004
1Danazol (Azol)FDA LinkGeneric
12/2002
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2002

Therapy/Procedure

12Hematopoietic Stem Cell Transplantation
01/2022 - 01/2004
9Transplantation
01/2022 - 09/2004
7Therapeutics
01/2022 - 12/2002
6Stem Cell Transplantation
03/2015 - 12/2002
3Drug Therapy (Chemotherapy)
03/2015 - 12/2002
1Splenectomy
01/2019
1Chelation Therapy (Therapy, Chelation)
10/2011